GNPRH Co-Investigators/ Technical Support
- William W. Andrews Ph.D., M.D.
- Shrikant I. Bangdiwala, Ph.D.
- Gary Darmstadt, M.D.
- Sarah Hawkes, MB, BS, Ph.D.
- W. Charles Huskins, M.D., M.S.
- Dwight J. Rouse, M.D.
- Cynthia G. Whitney, M.D., M.P.H.
William W. Andrews Ph.D., M.D.
University of Alabama at Birmingham,
Dr. Andrews is a professor of Maternal-Fetal Medicine and Director of the Division of Obstetrics at the University of Alabama at Birmingham (UAB). He is also the director of the UAB Obstetrics and Gynecology Infectious Disease Research Laboratory. His primary research interests are obstetrical, genital tract, and sexually transmitted infections. A particular emphasis of his research relates to genital tract infections associated with spontaneous preterm delivery.
Dr. Andrews has conducted many large clinical studies locally at UAB, nationally, and internationally. He has directed multi-center clinical trials on preterm birth prevention and has served as both a consultant and co-investigator for the Global Network for Perinatal and Reproductive Health. Most recently, he developed a color teaching atlas designed to provide instruction for laboratory technologists in the methods of interpretation of Gram-stained vaginal smears to diagnose bacterial vaginosis. This atlas was validated and used to instruct local technologists in eight different countries participating in a recent clinical trial conducted by the Global Network for perinatal and Reproductive Health.
Under his direction, the Ob/Gyn Infectious Disease Laboratory has provided microbiological and other laboratory support for many local and multi-center projects. Dr. Andrews is also a past principal investigator and current co-principal investigator for the National Institute of Child Health and Human development Maternal-Fetal Medicine Units Network.
Within this Network, he served as the Project Director for the recently completed 12-center randomized antibiotic trial to prevent preterm delivery in fetal fibronectin positive women. He currently leads a team of NICHD and UAB investigators conducting a longitudinal study of altered vaginal microbial flora. The objectives of this study include determining the natural history, contributing factors, and pathophysiology of altered vaginal flora.
Shrikant I. Bangdiwala, PhD
University of North Carolina,
Chapel Hill, North Carolina, USA
Dr. Bangdiwala is currently a Full Professor of Research in the Department of Biostatistics at the School of Public Health of the University of North Carolina at Chapel Hill, NC. He obtained his Ph.D. in Biostatistics in 1980, also at UNC. He has extensive experience in the statistical aspects of designing, conducting and analyzing complex multicenter epidemiological studies and clinical trials. He has specific content experience in research in injury prevention and control, cardiovascular disease, child abuse and neglect, HIV/AIDS, maternal and child health, and gastrointestinal disorders. His main teaching activities involve nonparametric methods and clinical trials design and analysis. He has extensive international experience in teaching, service and research. He has held visiting professor appointments at Universidad de La Frontera and Universidad de Vaparaíso (Chile), The University of Newcastle (Australia), and Universidad de Costa Rica. In addition, he has served as short-term statistical advisor to international health organizations (Pan American Health Organization, World Health Organization), as member of governmental grant review panels, as member and chair of several data and safety monitoring boards, and as statistical consultant to editorial boards of medical journals. He has over 129 publications, 121 oral presentations, and has conducted over 92 workshops on statistical methodology worldwide.
Gary Darmstadt, MD
Johns Hopkins Bloomberg School of Public Health, Department of International Health
Baltimore, Maryland, USA
Gary L. Darmstadt is Assistant Professor and director of neonatal health research and training in the Department of International Health in the Johns Hopkins Bloomberg School of Public Health. He also serves as Senior Research Advisor for the Saving Newborn Lives Initiative of Save the Children Federation.
Dr. Darmstadt is a pediatric infectious disease specialist with a focus on diseases of the neonate. He trained in Pediatrics at Johns Hopkins and also completed training in Dermatology at Stanford University, and in Pediatric Infectious Diseases at the University of Washington, where he was Assistant Professor in the Departments of Pediatrics and Medicine prior to joining Save the Children in September 2000. He joined the faculty at Johns Hopkins in September 2002. Dr. Darmstadt is recognized as a leader in neonatal health research in developing countries, and has numerous publications in this and related fields.
He currently is involved in several large-scale intervention trials. His research is aimed primarily at developing improved strategies for prevention, detection and management of bacterial infections in neonates in developing countries; and understanding and promoting newborn care practices and management of illness in the home and community in developing countries.
Sarah Hawkes, MB, BS, Ph.D
London School of Hygiene and Tropical Medicine
London, England, UK
Sarah Hawkes is a physician with a background in social science training at undergraduate level. At post-graduate level has a Ph.D in Clinical Epidemiology from the London School of Hygiene and Tropical Medicine.
Although clinically trained in infectious diseases, her focus has been in the field of sexual health in general, and sexually transmitted infections (including HIV) in particular. She has undertaken research in this area since 1991, in the UK, West and East Africa, and south Asia. Dr. Hawkes' work in south Asia has focused on the prevention and control of sexually transmitted infections, with a particular emphasis on their control in situations of low prevalence. She has published both epidemiological and policy work in this area, and the latter has been taken up by WHO at a global level. She works as a Clinical Senior Lecturer at the London School of Hygiene and Tropical Medicine.
W. Charles Huskins, M.D., M.S.
Mayo Clinic, Mayo Medical School,
Rochester, Minnesota, U.S.A.
Dr. Huskins is a Senior Associate in Pediatric Infectious Diseases, the Hospital Epidemiologist for the Mayo Eugenio Litta Children’s Hospital, and an Assistant Professor of Pediatrics at Mayo Medical School. He received a Masters of Science in Epidemiology (concentration in clinical epidemiology) from the Harvard School of Public Health in 1998.
His primary research activity has involved designing practical approaches for assisting hospitals in low- and middle-income countries to improve their programs for preventing healthcare associated infections, including perinatal infections affecting women and their newborn infants. He collaborated with members of the GNPRH in an international survey of practice variation in the use of antimicrobial prophylaxis for cesarean section and in the design of a multi-center intervention to improve use of antimicrobial prophylaxis.
Dwight J. Rouse, M.D.
School of Medicine, University of Alabama at Birmingham
Birmingham, Alabama, USA
Dr. Rouse is Associate Professor of Obstetrics and Gynecology. He is Principal Investigator for UAB in the NICHD Maternal-Fetal Medicine Units Network. He is the recipient of a 5 year NICHD K-24 Mid-Career Investigator Award (7/00-6/05), one of the main purposes of which is to enable him to conduct international multi-centered clinical trials. He is one of three UAB investigators funded by the Bill and Melinda Gates Foundation to establish an electronic perinatal medical record system in Lusaka, Zambia (Project Period 7/01 to 6/05).
He is completing an NICHD-funded single center chlorhexidine vaginal cleansing trial (Project Period 1/99-12/01) which is modeled on an earlier pilot trial of 1000 women that he conducted from 1994-1996. He is a Masters of Science of Public Health candidate in Epidemiology at the UAB School of Public Health, and has authored or co-authored 40 peer-reviewed articles, including influential clinical articles on labor management, and much-cited decision and cost-effectiveness analyses.
Cynthia G. Whitney, M.D., MPH
Centers for Disease Control and Prevention (CDC)
Respiratory Disease Branch, Division of Bacterial and Mycotic Diseases,
Atlanta, Georgia, USA
Cynthia Whitney is a Acting Chief the Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases in Atlanta. She is currently responsible for surveillance and prevention activities for pneumococcal disease, including tracking antimicrobial resistant pathogens, and development of vaccine policy. She oversees prevention efforts and applied public health research on bacterial causes of pneumonia and sepsis and is involved with prevention activities related to neonatal group B streptococcal disease, including development of guidelines for the prevention of neonatal group B streptococcal disease and assessments of the effectiveness of prevention efforts.
Dr. Whitney received her M.D. degree from the University of Minnesota (1990), completed post-graduate medical training in internal medicine at the University of Minnesota (1993), participated in the CDC's Epidemic Intelligence Service (EIS, 1993-1995), completed a preventive medicine residency with CDC, including working for a year with the Chicago Department of Public Health (1995-1996), and has an MPH from Harvard School of Public Health (1996-1997).